Bristol Myers Squibb is deploying NVIDIA's latest AI computing platform to accelerate drug discovery, clinical research and AI-driven pharmaceutical innovation.
Bristol Myers Squibb is deploying NVIDIA's latest AI computing platform to accelerate drug discovery, clinical research and AI-driven pharmaceutical innovation.